Gaddis Premier Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$534K Buy
445
+10
+2% +$10.2K 0.32% 51
2026
Q1
$400K Hold
435
– – 0.3% 56
2025
Q4
$468K Buy
+435
New +$416K 0.35% 50

Other funds holding LLY

Gaddis Premier Wealth Advisors's LLY Position: Q2 2026 in Review

Gaddis Premier Wealth Advisors increased its Eli Lilly (LLY) stake by 2.3% in Q2 2026, buying an estimated $10.2K and bringing the position to 445 shares worth $534K. The position accounts for 0.32% of the portfolio, ranked #51.

Gaddis Premier Wealth Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Gaddis Premier Wealth Advisors held 445 shares of Eli Lilly worth $534K as of Q2 2026.
  • Gaddis Premier Wealth Advisors bought 10 Eli Lilly shares in Q2 2026, an estimated $10.2K.
  • Eli Lilly made up 0.32% of Gaddis Premier Wealth Advisors's portfolio in Q2 2026, its #51 holding.
  • Gaddis Premier Wealth Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Gaddis Premier Wealth Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.